Optimizing Analgesia for Endometrial Biopsy
1 other identifier
interventional
197
1 country
1
Brief Summary
Comparison of the effectiveness of intrauterine lidocaine-paracervical block-dexketoprofen tromematol- lidocaine spray in endometrial biopsy analgesia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 2, 2024
CompletedFirst Posted
Study publicly available on registry
August 6, 2024
CompletedAugust 9, 2024
March 1, 2022
1 month
August 2, 2024
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparing analgesics in endometrial biopsy using The Visual Analogue Scale (VAS).
post operative VAS scores will be compared for each drug.The VAS measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). In this context, higher scores represent worse results.
1 hour
Study Arms (4)
Patients using intrauterine lidocaine for analgesia
ACTIVE COMPARATORPatients using oral dexketoprofen for analgesia
ACTIVE COMPARATORPatients using cervical lidocaine spray for analgesia
ACTIVE COMPARATORPatients using paracervical block with prilocaine for analgesia
ACTIVE COMPARATORInterventions
comparing the effectiveness of analgesics in endometrial biopsy
Eligibility Criteria
You may qualify if:
- women aged 18-75 needs endometrial biopsy
You may not qualify if:
- women with allergies to prilocaine, lidocaine or dexketoprofen trometamol
- women with a history of severe uncontrolled cardiovascular disease, diabetes mellitus, pregnancy, vaginal, cervical, or pelvic infection, cervical cancer, or severe cervical stenosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpaşa Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2024
First Posted
August 6, 2024
Study Start
September 1, 2022
Primary Completion
October 1, 2022
Study Completion
November 1, 2022
Last Updated
August 9, 2024
Record last verified: 2022-03